154 related articles for article (PubMed ID: 15047620)
1. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status.
Véricel E; Januel C; Carreras M; Moulin P; Lagarde M
Diabetes; 2004 Apr; 53(4):1046-51. PubMed ID: 15047620
[TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
3. Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes.
Abbate R; Pinto S; Panetta A; Favilla S; Prisco D; Paniccia R; Vanni D; Gensini GF; Neri Serneri GG
Prostaglandins Leukot Essent Fatty Acids; 1988 Jan; 31(1):9-15. PubMed ID: 3131781
[TBL] [Abstract][Full Text] [Related]
4. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
Katoh K
Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
[TBL] [Abstract][Full Text] [Related]
5. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
Jokl R; Klein RL; Lopes-Virella MF; Colwell JA
Diabetes Care; 1995 Aug; 18(8):1150-5. PubMed ID: 7587850
[TBL] [Abstract][Full Text] [Related]
6. Effects of vitamin E administration on platelet function in diabetes mellitus.
Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications.
Ratzmann KP; Schimke E; Beitz A; Hildebrandt R; Taube C
Klin Wochenschr; 1991 Sep; 69(14):652-6. PubMed ID: 1749204
[TBL] [Abstract][Full Text] [Related]
8. Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients.
Véricel E; Colas R; Calzada C; Lê QH; Feugier N; Cugnet C; Vidal H; Laville M; Moulin P; Lagarde M
Thromb Haemost; 2015 Aug; 114(2):289-96. PubMed ID: 25832443
[TBL] [Abstract][Full Text] [Related]
9. In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase.
Calzada C; Coulon L; Halimi D; Le Coquil E; Pruneta-Deloche V; Moulin P; Ponsin G; Véricel E; Lagarde M
J Clin Endocrinol Metab; 2007 May; 92(5):1961-4. PubMed ID: 17341567
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
[TBL] [Abstract][Full Text] [Related]
11. Increased production of platelet thromboxane B2 in non-insulin-dependent diabetes. Relationship to vascular complications.
D'Angelo A; Micossi P; Mannucci PM; Garimberti B; Franchi F; Pozza G
Eur J Clin Invest; 1984 Apr; 14(2):83-6. PubMed ID: 6428908
[TBL] [Abstract][Full Text] [Related]
12. Effect of garden cress in reducing blood glucose, improving blood lipids, and reducing oxidative stress in a mouse model of diabetes induced by a high-fat diet and streptozotocin.
Chen X; Yuan H; Shi F; Zhu Y
J Sci Food Agric; 2020 Mar; 100(5):2074-2081. PubMed ID: 31875960
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation in diabetic patients with asymptomatic atherosclerosis.
Kawamori R; Imano E; Watarai T; Nishizawa H; Matsushima H; Kodama M; Yamasaki Y; Kamada T
Diabetes Res Clin Pract; 1994 Jun; 24(2):89-95. PubMed ID: 7956714
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.
Domínguez C; Ruiz E; Gussinye M; Carrascosa A
Diabetes Care; 1998 Oct; 21(10):1736-42. PubMed ID: 9773740
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
Julier K; Mackness MI; Dean JD; Durrington PN
Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.
Queen LR; Ji Y; Goubareva I; Ferro A
Diabetologia; 2003 Nov; 46(11):1474-82. PubMed ID: 14574451
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin E on platelet aggregation in diabetes mellitus.
Watanabe J; Umeda F; Wakasugi H; Ibayashi H
Thromb Haemost; 1984 Jul; 51(3):313-6. PubMed ID: 6495252
[TBL] [Abstract][Full Text] [Related]
18. Serum alpha-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and without angiopathy.
Skrha J; Prázný M; Hilgertová J; Weiserová H
Clin Chim Acta; 2003 Mar; 329(1-2):103-8. PubMed ID: 12589972
[TBL] [Abstract][Full Text] [Related]
19. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus.
Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L
Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications.
Martín-Gallán P; Carrascosa A; Gussinyé M; Domínguez C
Free Radic Biol Med; 2003 Jun; 34(12):1563-74. PubMed ID: 12788476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
